| Enhancer ID: | E_01_0569 |
| Species: | human |
| Position : | chrX:15492185-15494185 |
| Biosample name: | |
| Experiment class : | High+Lowthroughput |
| Enhancer type: | Enhancer |
| Disease: | The novel coronavirus |
| Pubmed ID: | 32511315 |
| Enhancer experiment: | ChIP-seq?RNA-seq |
| Enhancer experiment description: | The ACE2 gene is expressed in SARS-CoV-2 target cells, including Type II Pneumocytes (Ziegler, 2020), and is activated by interferons. |
| Target gene : | ACE2 |
| Strong evidence: | qRT-PCR,qPCR,ChIP,3C |
| Less strong evidence: | RNA-Seq |
| Target gene experiment description: | The ACE2 gene is expressed in SARS-CoV-2 target cells, including Type II Pneumocytes (Ziegler, 2020), and is activated by interferons. |
| TF name : | -- |
| TF experiment: | ChIP-seq?RNA-seq |
| TF experiment description: | The ACE2 gene is expressed in SARS-CoV-2 target cells, including Type II Pneumocytes (Ziegler, 2020), and is activated by interferons. |
| Enhancer function : | The ACE2 gene is expressed in SARS-CoV-2 target cells, including Type II Pneumocytes (Ziegler, 2020), and is activated by interferons. |
| Enhancer function experiment: | Immunohistochemical staining |
| Enhancer function experiment description: |
The ACE2 gene is expressed in SARS-CoV-2 target cells, including Type II Pneumocytes (Ziegler, 2020), and is activated by interferons. |
| SNP ID: | -- |
| GeneName | Pathway Name | Source | Gene Number |
|---|